PROSTATE
CANCER CRYOTHERAPY
Overview
Types of Prostate Cancer:
Prostatic Sarcoma
Prostatic sarcoma is an extremely rare prostate cancer type. It accounts for less than 0.1 percent of primary prostate cancer types in adults. The most common subtype of prostatic sarcoma is leiomyosarcoma.
A prostatic sarcoma occurs in relatively younger men between the ages of 35 and 60. Most men with prostate cancer prognosis experience signs of prostate cancer including:
• Bladder flow obstruction
• Weak stream
• Urinary strain and frequency
• Nocturia (excessive urination at night)
The mass size of the tumor is likely responsible for these prostate cancer symptoms. Often times, the tumor is very large. The tumor is made up of prostate cancer cell types that are capable of developing into connective tissues, blood, lymphatic vessels, and blood vessels originating from smooth muscles of the prostate.
Diagnosing Rare Types of Prostate Cancer
It is impossible to make the diagnosis by rectal examinations, as the tumor is often a smooth and firm enlargement of the prostate. A prostate diagnosis may be unsuspected at the time of examination. Twenty-five percent of cases are presented with metastatic diseases at the time of diagnosis. Prostatic sarcoma remains localized for a viable period of time before it spreads locally to the bladder, rectum or perineum. Over more time the tumor will spread to distant locations like the lungs, brain, bone or liver. The most common sites of distant metastasis are the lungs. A biopsy and the opinion of an experience pathologist in the proper diagnosis cannot be over-emphasized.
Many more tests may be done to determine if the tumor has grown to other areas of the body. A magnetic resonance imaging (MRI) or computer tomography (CT) scans may be administered for this purpose.
Treatment For Prostate Cancer Prostatic Sarcoma
Due to the rarity of prostatic sarcoma, there is a lack of data available for doctors to study. As a result, prostate cancer treatment options are difficult to establish. Most doctors currently, if feasible, use radical surgery in an attempt to remove the tumor with a combination of prostate cancer radiation treatment or chemotherapy. However, it is unclear as to which prostate cancer treatment offers the greatest hope. Regardless of treatment, the prostate cancer prognosis remains poor. Recorded data has found patients to be cured of local prostatic sarcoma – showing no signs of prostate cancer recurrence. However, all patients have eventually died due to the disease disseminating to other areas of the body within a few years of the diagnosis. |
